Connor, Clark & Lunn Investment Management (CC&L)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
|
|||||
|
2025
Q1 | $5.64M | Sell |
|
|||||
|
2024
Q4 | $7.29M | Sell |
|
|||||
|
2024
Q3 | $6.7M | Buy |
|
|||||
|
2024
Q2 | $2.34M | Buy |
|
|||||
|
2024
Q1 | $2.77M | Sell |
|
|||||
|
2023
Q4 | $3.01M | Buy |
|
|||||
|
2023
Q3 | $2.22M | Buy |
|
|||||
|
2023
Q2 | $1.69M | Buy |
|
|||||
|
2023
Q1 | $630K | Buy |
|
|||||
|
2022
Q4 | $480K | Buy |
|